Stoke Therapeutics, Inc. STOK Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s interest coverage?
- Stoke Therapeutics, Inc. (STOK) reported interest coverage of -13× in Q1 2026.
- How has Stoke Therapeutics, Inc.'s interest coverage changed year-over-year?
- Stoke Therapeutics, Inc.'s interest coverage decreased by 544.8% year-over-year, from 2.9× to -13×.
- What is the long-term trend for Stoke Therapeutics, Inc.'s interest coverage?
- Over 4 years (2021 to 2025), Stoke Therapeutics, Inc.'s interest coverage has grown at a -78.6% compound annual growth rate (CAGR), from -717.2× to -1.5×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.